Portfolio News
- August 17, 2010 Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
- August 17, 2010 - XconomyKaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader
- August 10, 2010 Amarin Reports Q2 2010 Results
- August 10, 2010 Amarin’s AMR101 Pivotal Phase 3 MARINE Clinical Trial Ccmpletes Patient Enrollment and Randomization
- August 04, 2010 Movetis Receives Authorisation to Market Resolor in Switzerland
- August 03, 2010 Movetis Receives a Tender Offer from Shire of €19 Cash Per Share for All Outstanding Shares and Warrants
- August 03, 2010 Trius Therapeutics Announces Pricing for Initial Public Offering
- July 12, 2010 - Dow Jones Investment BankerTHE REMEDY: Amarin's Lessons In Crisis Management
- July 08, 2010 Infinity and Intellikine Enter Agreement to Develop Oral Therapies Targeting PI3 Kinase Delta, Gamma
- June 30, 2010 Vicept Therapeutics Secures $10 Million to Complete Series A Funding; Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders
- June 23, 2010 Anthera Enrolls First Patients in Pivotal Varespladib Phase 3 Clinical Study
- June 16, 2010 KXEN Secures $8 Million in Series D Funding
- June 04, 2010 Ascenta Therapeutics Licenses Cancer Drug Candidates to Sanofi-Aventis
- June 04, 2010 - The Wall Street Journal OnlineThe $100M Revenue Club: Cortina Systems, Powered By Intel
- June 01, 2010 HelloSoft Presents TriPhone, a $100 4G Android-based Trimode Reference Handset